1. Home
  2. ELVN vs ACDC Comparison

ELVN vs ACDC Comparison

Compare ELVN & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$34.61

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

HOLD

Current Price

$6.84

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELVN
ACDC
Founded
2016
2014
Country
United States
United States
Employees
61
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ELVN
ACDC
Price
$34.61
$6.84
Analyst Decision
Strong Buy
Sell
Analyst Count
5
2
Target Price
$43.40
$5.50
AVG Volume (30 Days)
684.5K
1.4M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
3.17
N/A
EPS
N/A
N/A
Revenue
N/A
$1,941,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.79
$3.08
52 Week High
$48.53
$10.70

Technical Indicators

Market Signals
Indicator
ELVN
ACDC
Relative Strength Index (RSI) 31.34 48.83
Support Level $25.63 $5.82
Resistance Level $40.62 $7.85
Average True Range (ATR) 2.02 0.61
MACD -0.84 0.00
Stochastic Oscillator 4.80 44.16

Price Performance

Historical Comparison
ELVN
ACDC

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.

Share on Social Networks: